First Time Loading...

Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 40.05 HKD 0.63% Market Closed
Updated: May 17, 2024

Innovent Biologics Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innovent Biologics Inc
Research & Development Peer Comparison

Comparables:
6160
603392
S
002252
300122
300896

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Innovent Biologics Inc
HKEX:1801
Research & Development
-¥2.1B
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Research & Development
-¥12.5B
CAGR 3-Years
-13%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Research & Development
-¥1.1B
CAGR 3-Years
-54%
CAGR 5-Years
-54%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Research & Development
-¥177.8m
CAGR 3-Years
-11%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Research & Development
-¥988.6m
CAGR 3-Years
-47%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
Imeik Technology Development Co Ltd
SZSE:300896
Research & Development
-¥168.2m
CAGR 3-Years
-54%
CAGR 5-Years
-44%
CAGR 10-Years
N/A

See Also

What is Innovent Biologics Inc's Research & Development?
Research & Development
-2.1B CNY

Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Research & Development amounts to -2.1B CNY.

What is Innovent Biologics Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-12%

Over the last year, the Research & Development growth was 26%. The average annual Research & Development growth rates for Innovent Biologics Inc have been -4% over the past three years , -12% over the past five years .